Description
This text presents difficult management issues surrounding women with epilepsy in a unique format. The Editors provide several controversial cases in adolescence, pre-conception, pregnancy and menopause with invited experts offering their differing opinions. The Editors compare the clinical approaches and build a consensus based on the best available evidence. Professionals charged with managing this challenging patient group will be given insights on providing the best possible care based on current available data and expert opinion. Mona Sazgar, MDProfessor of Clinical NeurologyComprehensive Epilepsy Program, University of California, Irvine, Orange, CA, USA Cynthia L. Harden, MDSystem Director of Epilepsy Services, Mount Sinai Health SystemMount Sinai Beth Israel Phillips Ambulatory Care Center10 Union Square East, Suite 5DNew York, NY 10003Phone 212-844-8888 Fax 212-844-8481charden@CHPNET.ORG I. Adolescence 1. New Onset Primary Generalized Epilepsy in Adolescence 2. New Onset Partial Epilepsy in Adolescence 3. Catamenial Epilepsy in Adolescence 4. Contraception Choice in Adolescence II. Pre-Conception Counseling5. Folic Acid Supplementation 6. Risk of Seizure during Pregnancy 7. Seizure Medications and Teratogenicity 8. Valproic Acid and Pregnancy: Failed Other Medications 9. Valproic Acid and Pregnancy: Not Tried Other Medications 10. Epilepsy Inheritance 11. Infertility and Menstrual Disorders: Seizure Medications vs. Seizures 12. Ever Advise Against Pregnancy? III. Pregnancy/Breast Feeding13. New Onset Seizures during Pregnancy 14. Valproic Acid and Pregnancy 15. Lamictal and Pregnancy 16. What is Your Advice to Pregnant Women with Epilepsy Regarding Breast Feeding? IV. Menopause17. Change in Seizure Pattern and Menopause 18. Peri-Menopausal Symptoms in Women with Epilepsy 19. Bone Health in Women with Epilepsy
